Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA

BACKGROUND: The optimal posttreatment surveillance strategy for nasopharyngeal carcinoma (NPC) remains unclear. Circulating cell-free Epstein-Barr virus (cfEBV) DNA has been recognized as a promising biomarker to facilitate early detection of NPC recurrence. Therefore, we aim to determine whether in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chen-Fei, Lin, Li, Mao, Yan-Ping, Deng, Bin, Lv, Jia-Wei, Zheng, Wei-Hong, Wen, Dan-Wan, Kou, Jia, Chen, Fo-Ping, Yang, Xing-Li, Xu, Si-Si, Ma, Jun, Zhou, Guan-Qun, Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390246/
https://www.ncbi.nlm.nih.gov/pubmed/34433440
http://dx.doi.org/10.1186/s12916-021-02076-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390246/
https://www.ncbi.nlm.nih.gov/pubmed/34433440
http://dx.doi.org/10.1186/s12916-021-02076-4

Ejemplares similares